Detalhe da pesquisa
1.
Autoreactivity to self-antigens LL37 and ADAMTSL5 influences the clinical response to risankizumab in psoriatic patients.
J Autoimmun;
147: 103244, 2024 May 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38797050
2.
A randomized, double-blind, phase III study assessing clinical similarity of SB17 (proposed ustekinumab biosimilar) to reference ustekinumab in subjects with moderate-to-severe plaque psoriasis.
J Am Acad Dermatol;
2024 Apr 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38685404
3.
Short-, mid- and long-term efficacy of dupilumab in moderate to severe atopic dermatitis: a real life multicenter Italian study on 2576 patients.
Clin Exp Dermatol;
2024 Jun 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38860563
4.
Fast and safe clinical response to sonidegib in a 98-year old woman affected by locally advanced basal cell carcinoma.
Dermatol Online J;
30(1)2024 Mar 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38762862
5.
Atopic Dermatitis in the Elderly Population.
Acta Derm Venereol;
103: adv13363, 2023 Dec 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38095061
6.
The Treat-to-Target Project in Atopic Dermatitis: One Year On.
Acta Derm Venereol;
103: adv5382, 2023 Apr 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37083095
7.
Real-life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52-week multicentre retrospective study-IL PSO (Italian landscape psoriasis).
J Eur Acad Dermatol Venereol;
37(1): 93-103, 2023 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36156312
8.
Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis.
Ann Rheum Dis;
81(1): 68-73, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34144965
9.
Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials.
Br J Dermatol;
187(6): 888-899, 2022 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36082590
10.
Risk of lymphohematologic malignancies in patients with chronic plaque psoriasis: A systematic review with meta-analysis.
J Am Acad Dermatol;
86(1): 86-96, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34363908
11.
Real life long-term efficacy and safety of ixekizumab in moderate-to-severe psoriasis: A 192 weeks multicentric retrospective study-IL PSO (Italian landscape psoriasis).
Dermatol Ther;
35(8): e15608, 2022 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35638250
12.
Hypochondriasis and Personality Traits of Patients with Chronic Plaque Psoriasis.
Dermatology;
238(2): 276-282, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34325430
13.
Contact allergy in children with and without atopic dermatitis: An Italian multicentre study.
Contact Dermatitis;
87(3): 265-272, 2022 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35451136
14.
Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis.
J Cutan Med Surg;
26(3): 249-255, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34894782
15.
A case of nivolumab-induced bullous pemphigoid successfully treated with dupilumab.
Dermatol Online J;
28(2)2022 Mar 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35670683
16.
Pyoderma gangrenosum associated with pseudo-Pelger-Huet anomaly in a patient with idiopathic myelofibrosis.
Dermatol Online J;
28(6)2022 Dec 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36809097
17.
The pruritogenic role of the type 2 immune response in diseases associated with chronic itch.
Exp Dermatol;
30(9): 1208-1217, 2021 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34033148
18.
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry.
Allergy;
76(6): 1813-1824, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34152613
19.
The safety profile of hydroxychloroquine: major cutaneous and extracutaneous adverse events.
Clin Exp Rheumatol;
39(5): 1099-1107, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33635229
20.
Psoriasis is not associated with cognition, brain imaging markers, and risk for dementia: The Rotterdam Study.
J Am Acad Dermatol;
85(3): 671-680, 2021 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30092331